Goldman Sachs Future Health Care Equity ETF (GDOC)
| Assets | $99.61M |
| NAV | $28.46 |
| Expense Ratio | 0.75% |
| PE Ratio | 28.17 |
| Shares Out | 3.50M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| 1-Year Return | -27.87% |
| Volume | 2,205 |
| Open | 28.15 |
| Previous Close | 28.98 |
| Day's Range | 28.07 - 28.22 |
| 52-Week Low | 26.97 |
| 52-Week High | 39.29 |
| Beta | 1.23 |
| Holdings | 60 |
| Inception Date | Nov 9, 2021 |
About GDOC
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.
Top 10 Holdings
39.80% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 6.40% |
| AstraZeneca PLC | AZN.L | 4.96% |
| Boston Scientific | BSX | 4.13% |
| Edwards Lifesciences | EW | 3.92% |
| Seagen | SGEN | 3.79% |
| Neurocrine Biosciences | NBIX | 3.62% |
| Intuitive Surgical | ISRG | 3.43% |
| West Pharmaceutical Services | WST | 3.43% |
| CSL Ltd | CSL.AX | 3.07% |
| Bristol-Myers Squibb Company | BMY | 3.05% |
News
Thematic Investing With Goldman Sachs: Episode 3 – GS Future Health Care Equity ETF (GDOC)
In the Thematic Investing series, Tom Lydon, CEO of ETF Trends and ETF Database, alongside experts and innovators from Goldman Sachs, sheds light on one of the most popular alternative investments, them...
Some Old School Stocks Help Futuristic Healthcare ETF
When many investors think of healthcare innovation, they focus on companies in industries such as biotechnology, medical devices, telehealth and more. Exchange traded funds, including the Goldman Sachs ...
GDOC: Right ETF for New Era of Healthcare Innovation
Healthcare innovation is a concept that was thrust into the investment spotlight due in large part to the coronavirus pandemic, but that doesn't mean the related investment thesis disappears if the worl...
Healthcare Innovation Outlook Constructive for GDOC
The Goldman Sachs Future Health Care Equity ETF (GDOC) debuted last month as the newest addition to an expanding realm of exchange traded funds focusing on disruptive healthcare concepts. That could amo...
New ETF Brings Needed Refresh to Real Estate Investing
As a standalone sector, real estate is just several years old, and it's one of the smaller sector weights in the S&P 500. That said, equity real estate investing has served investors well for decades.
Rookie Retail ETF Arrives at Just the Right Time
Good timing is helpful to any new exchange traded fund, but not all have it. An example of a rookie ETF that immediately appears to be well-timed is the Goldman Sachs Future Consumer Equity ETF (GBUY).
Go With GDOC for Futuristic Healthcare Exposure
Investors looking disruptive and innovative growth concepts often hone in on the communication services and technology sectors, and rightfully so, but they'd do well to add healthcare to that mix. In fa...
Goldman Sachs Expands Thematic Offerings With Three New ETFs
Goldman Sachs Asset Management has launched three new actively managed thematic ETFs to add to their suite of funds focused on innovation and disruption: the Goldman Sachs Future Consumer Equity ETF (GB...
Goldman Sachs is building on the disruptive investing theme with a trio of new ETFs
Goldman Sachs Group is offering investors new ways to seek equity gains from disruptive companies, with its asset management business launching three exchange-traded funds focused on secular growth trends.